Showing 15,501 - 15,520 results of 41,669 for search '(( 50 ((((we decrease) OR (nn decrease))) OR (a decrease)) ) OR ( a point decrease ))', query time: 0.88s Refine Results
  1. 15501
  2. 15502

    Relationship between toxicity and oxidative stress of the nanoencapsulated colchicine in a model of <i>Drosophila melanogaster</i> by Franciéle Romero Machado (14428152)

    Published 2023
    “…As a result, acute exposure to the COL decreases the number of crosses in the open field and increases CAT activity. …”
  3. 15503

    Drug resistance from preferred antiretroviral regimens for HIV infection in South Africa: A modeling study by Ume L. Abbas (224384)

    Published 2019
    “…Using base case and uncertainty analyses, we assessed (majority) drug resistance levels.</p><p>Results</p><p>By 2030, the median total resistance (proportion of HIV-infected persons with drug resistance) is predicted to reach 31.4% (interquartile range (IQR): 16.5%-50.2%) with CD4-based ART, decreasing to 14.5% (IQR: 7.7%-25.8%) with Fast-track implementation. …”
  4. 15504
  5. 15505
  6. 15506
  7. 15507
  8. 15508
  9. 15509
  10. 15510
  11. 15511
  12. 15512
  13. 15513
  14. 15514

    Image_2_Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine.jpeg by Jae Hong Choi (3339120)

    Published 2022
    “…Background<p>Effective vaccines against coronavirus disease 2019 (COVID-19) are available worldwide; however, the longevity of vaccine effectiveness is not known.</p>Objective<p>We performed a prospective observational study to assess the antibody response of healthcare workers against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) after BNT162b2 mRNA COVID-19 vaccination.…”
  15. 15515

    Image_1_Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine.jpg by Jae Hong Choi (3339120)

    Published 2022
    “…Background<p>Effective vaccines against coronavirus disease 2019 (COVID-19) are available worldwide; however, the longevity of vaccine effectiveness is not known.</p>Objective<p>We performed a prospective observational study to assess the antibody response of healthcare workers against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) after BNT162b2 mRNA COVID-19 vaccination.…”
  16. 15516
  17. 15517

    Table_1_Association between brain structures and migraine: A bidirectional Mendelian randomization study.DOCX by Xiaoming Guo (2591026)

    Published 2023
    “…</p>Results<p>We identified suggestive associations of the decreased surface area (OR = 0.85; 95% CI, 0.75–0.96; P = 0.007), and decreased hippocampal volume (OR = 0.74; 95% CI, 0.55–1.00; P = 0.047) with higher migraine risk. …”
  18. 15518
  19. 15519
  20. 15520

    KCa3.1 ion channel: A novel therapeutic target for corneal fibrosis - Fig 7 by Govindaraj Anumanthan (4976273)

    Published 2018
    “…TRAM-34 (25 μM) +TGFβ1 treatment resulted in a significant decrease in α-SMA (c). Scale bar = 50 μm. …”